aMAP Risk Score Predicts HCC Development in Patients With Chronic Hepatitis
Hepatocellular carcinoma (HCC) almost invariably develops in the background of chronic hepatitis, but the risk varies greatly among individual patients. Fan and colleagues pooled data from 11 cohorts of mostly patients with treated chronic hepatitis to develop a new HCC risk score, which was built on five component variables, including age, male sex, serum level of albumin, serum level of bilirubin, and blood platelet count
- – All
All-Oral Direct-Acting Antiviral Treatments Improve Survival in Patients with HCV-Related Hepatocellular Carcinoma
Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that hepatitis C
- – Medscape
Hep B Liver Cancer Risk Comparable With Tenofovir, Entecavir
Chronic hepatitis B patients face similar risk liver cancer risks whether treated with tenofovir or entecavir, according to a systematic review and meta-analysis.
- – AASLD News
Hep C Cure Linked to Lower Mortality From Liver Cancer
Boston—Curing infection with the hepatitis C virus appears to dramatically improve five-year survival rates in people with liver cancer whose tumors are caused by the infection, a new study has found.
- – Department of Medicine
Department of Medicine Launches Faculty Diversity LENS
The DOM Faculty Diversity LENS was launched on January 1, 2019 to improve the diversity of the Department’s faculty searches, candidate evaluations, and outreach efforts.